British Journal of Anaesthesia, Vol 83, Issue 4 673-674, Copyright © 1999 by The Board of Management and Trustees of the British Journal of Anaesthesia
B. Gustorff, P. Lierz, P. Felleiter, T. H. Knocke, K. Hoerauf and H. G. Kress
Ropivacaine is assumed to be less toxic than bupivacaine but there are no
reports concerning its long-term use in paediatric anaesthesia. We report
the use of ropivacaine for long-term epidural anaesthesia in a 21-month-old
girl. In two consecutive periods of 3 days each, 0.5% bupivacaine and 0.5%
or 0.75% ropivacaine were administered to facilitate painful vaginal
brachytherapy. The mean dose of bupivacaine increased from 1.05 to 1.32 mg
kg-1 h-1 and that of ropivacaine increased from 1.40 to 3.86 mg kg-1 h-1.
No toxic side effects were observed. We conclude that both epidural
ropivacaine and bupivacaine were effective and safe during long-term
epidural anaesthesia in this particular case. However, the doses were
potentially toxic and should therefore be used with extreme caution.
CASE REPORTS
Ropivacaine and bupivacaine for long-term epidural infusion in a small child
Department of Anaesthesiology and General Intensive Care (B) and Department of Radiotherapy and Radiobiology, University of Vienna, Austria
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Benrath, S. Kozek-Langenecker, M. Hupfl, P. Lierz, and B. Gustorff Anaesthesia for brachytherapy--51/2 yr of experience in 1622 procedures Br. J. Anaesth., February 1, 2006; 96(2): 195 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.S. Morton Editorial II: Ropivacaine in children Br. J. Anaesth., September 1, 2000; 85(3): 344 - 346. [Full Text] [PDF] |
||||
